MyFinsight
Home
Blog
About
Zymeworks Inc. (ZYME)
Zymeworks Inc. (ZYME)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$31,948K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from marketable securit...
Stock-based compensation expense
Non-cash interest expense relate...
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Purchases of common stock for re...
Net loss
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Segment loss
-
-
-34,219
-13,646
Depreciation and amortization
-
-
1,083
1,553
Stock-based compensation expense
-
-
8,850
6,911
Change in contingent consideration
-
-
0
0
Impairment on ipr&d (note 6)
-
-
0
0
Interest income
-
-
2,975
3,529
Other (expense) income, net (note 12)
-
-
-302
315
Income tax (expense) recovery, net
-
-
-270
1,336
Net loss
-45,019
-44,162
-41,209
-19,602
Depreciation of property and equipment
957
963
898
905
Amortization of intangible assets
176
176
185
648
Stock-based compensation expense
11,334
6,935
8,850
6,911
Amortization of operating lease right-of-use assets
821
1,708
924
1,031
Amortization of debt issuance costs
87
26
-
-
Non-cash royalty revenue related to sale of royalties
467
-
-
-
Impairment of acquired ipr&d (note 6)
-
-
0
0
Non-cash interest expense related to sale of royalties
6,508
2,040
-
-
Deferred income tax recovery
-265
2,200
-1,410
170
Change in fair value of contingent consideration liability (note 15)
-
-
0
0
Change in fair value of investments in equity instruments
-
-
0
-
Unrealized foreign exchange (gain) loss
301
331
-305
451
Accounts receivable
1,256
36
-24,713
26,721
Prepaid expenses and other current assets
383
1,726
5,120
-3,267
Accounts payable and accrued liabilities
-3,617
-7,750
1,335
3,341
Operating lease liabilities
-783
-1,005
-838
-872
Deferred revenue
-248
-340
-779
-614
Income taxes payable
-22
-16
-933
915
Net cash (used in) provided by operating activities
-31,948
-45,718
-10,259
-31,412
Purchases of marketable securities
62,532
0
56,828
35,054
Proceeds from marketable securities
79,606
70,175
62,916
35,832
Acquisition of property and equipment
0
216
581
410
Proceeds from issuance of common stock under at-the-market program and from public offerings, net of issuance costs (notes 10a)
-
-
0
-
Acquisition of intangible assets
0
0
139
0
Private placement (note 10a)
-
-
0
4,988
Net cash provided by investing activities
17,074
69,959
5,368
368
Issuance of common stock on exercise of stock options
2,888
8,717
6,825
7,923
Issuance of common stock through employee stock purchase plan
0
607
0
881
Purchases of common stock for retirement
51,949
76,151
25,479
16,216
Proceeds from sale of future royalties
0
250,000
-
-
Payments for transaction costs related to sale of future royalties
958
4,387
-
-
Deferred financing fees
0
-
88
28
Net cash provided by financing activities
-50,019
178,786
-18,742
-2,452
Effect of exchange rate changes on cash and cash equivalents
24
98
-44
77
Net change in cash and cash equivalents
-64,869
203,125
-23,677
-33,419
Cash and cash equivalents, beginning of period
244,282
41,157
64,834
66,103
Cash and cash equivalents, end of period
179,413
244,282
41,157
64,834
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from marketable
securities
$79,606K
(-36.98%↓ Y/Y)
Net cash provided by
investing activities
$17,074K
(-18.41%↓ Y/Y)
Effect of exchange rate
changes on cash and cash...
$24K
(130.77%↑ Y/Y)
Canceled cashflow
$62,532K
Net change in cash
and cash...
-$64,869K
(-301.77%↓ Y/Y)
Canceled cashflow
$17,098K
Issuance of common stock
on exercise of...
$2,888K
(33.95%↑ Y/Y)
Stock-based compensation
expense
$11,334K
(-7.65%↓ Y/Y)
Non-cash interest
expense related to sale...
$6,508K
Depreciation of property and
equipment
$957K
(-48.71%↓ Y/Y)
Amortization of operating
lease right-of-use...
$821K
(-42.59%↓ Y/Y)
Deferred income tax
recovery
-$265K
(-189.83%↓ Y/Y)
Amortization of intangible
assets
$176K
(-94.54%↓ Y/Y)
Amortization of debt issuance
costs
$87K
Purchases of marketable
securities
$62,532K
(-39.98%↓ Y/Y)
Net cash provided by
financing activities
-$50,019K
(-1998.25%↓ Y/Y)
Net cash (used in)
provided by operating...
-$31,948K
(-468.66%↓ Y/Y)
Canceled cashflow
$2,888K
Canceled cashflow
$20,148K
Purchases of common stock
for retirement
$51,949K
Net loss
-$45,019K
(-121.56%↓ Y/Y)
Payments for transaction
costs related to sale...
$958K
Accounts payable and
accrued liabilities
-$3,617K
(87.23%↑ Y/Y)
Accounts receivable
$1,256K
(102.36%↑ Y/Y)
Operating lease
liabilities
-$783K
(52.02%↑ Y/Y)
Non-cash royalty revenue
related to sale of...
$467K
Prepaid expenses and
other current assets
$383K
(104.58%↑ Y/Y)
Unrealized foreign
exchange (gain) loss
$301K
(144.40%↑ Y/Y)
Deferred revenue
-$248K
(98.86%↑ Y/Y)
Income taxes payable
-$22K
(18.52%↑ Y/Y)
Buy us a coffee